Workshops are new to CIC2016 this year. Plan to participate in two CAIRE supported workshops during the conference:
Weds, Dec 7 | 11:00-12:30
Mumps Vaccine Effectiveness, outbreak investigation
Workshop lead: Dr. Shelley Deeks (Public Health Ontario)
This case study on mumps is a real world example of how to assess vaccine effectiveness (VE) during an outbreak investigation. It is an opportunity for learners to bridge their background knowledge and scientific expertise with the skill of VE assessment to inform communications and recommendations during or after an outbreak investigation. Learners will use data from a real world example to determine the type of VE assessment that is appropriate for a given situation. This case study has been developed as one component of a learning module for an online advanced vaccinology course (Advanced VAccinology Learning ONline – AVALON). The VE module is the first component of AVALON to be developed and will educate future vaccine researchers, public health practitioners, and vaccine decision-makers in Canada.
- Describe why determination of VE is important;
- Explore data requirements and limitations of different approaches to assessing VE;
- Identify and apply formulas used to calculate VE.
In this workshop public health researchers, immunization policy makers, front line providers and clinical researchers will come together to learn about and discuss potential maternal pertussis immunization programs in Canada, including objectives, recent evidence, program feasibility and challenges. Maternal immunization is a rapidly expanding area of immunization but faces many challenges. Maternal immunization has been very effective in controlling infant pertussis recently in a number of countries. Given the cyclical nature of recurring pertussis peaks, the immunization community in Canada must consider how maternal pertussis immunization programs will be implemented and evaluated. Workshop delegates will specifically have the opportunity to review and discuss evidence pertinent to the risk-benefit and cost-effectiveness analyses relating to maternal pertussis immunization. Experience from other countries, both practical and scientific, and how Canada might appropriately consider such programs during an outbreak or for routine use will be covered.
- To review the considerations, conditions and thresholds for maternal pertussis immunization, including experience elsewhere and applicability within Canada;
- To explore challenges in Canada and how these can be mitigated;
- To discuss infrastructure and evaluation needed to monitor the program in relation to objectives and with respect to acceptance, risk-benefit and cost-effectiveness analyses.